|
Cohort1: dose level 1
|
| Administration route |
transrectal intraprostatic injection |
| Dosage |
1E9 vp |
| Age |
Adult, Older_Adult |
| Lymph depletion |
Yes |
| References |
PMID:
19343063
|
|
|
Cohort2: dose level 2
|
| Administration route |
transrectal intraprostatic injection |
| Dosage |
3.2E9 vp |
| Age |
Adult, Older_Adult |
| Lymph depletion |
Yes |
| References |
PMID:
19343063
|
|
|
Cohort3: dose level 3
|
| Administration route |
transrectal intraprostatic injection |
| Dosage |
1E10 vp |
| Age |
Adult, Older_Adult |
| Lymph depletion |
Yes |
| References |
PMID:
19343063
|
|
|
Cohort4: dose level 4
|
| Administration route |
transrectal intraprostatic injection |
| Dosage |
3.2E10 vp |
| Age |
Adult, Older_Adult |
| Lymph depletion |
Yes |
| References |
PMID:
19343063
|
|
|
Cohort5: dose level 5
|
| Administration route |
transrectal intraprostatic injection |
| Dosage |
1E11 vp |
| Age |
Adult, Older_Adult |
| Lymph depletion |
Yes |
| References |
PMID:
19343063
|
|
|
Cohort6: dose level 6
|
| Administration route |
transrectal intraprostatic injection |
| Dosage |
3.2E11 vp |
| Age |
Adult, Older_Adult |
| Lymph depletion |
Yes |
| References |
PMID:
19343063
|
|